FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta. 2023

Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
Department of Nutrition, Texas A&M University, College Station, Texas.

FoxO1 is an important transcriptional factor that regulates cell survival and metabolism in many tissues. Deleting FoxO1 results in embryonic death due to failure of chorioallantoic fusion at E8.5; however, its role in placental development during mid-late gestation is unclear. In both human patients with gestational diabetes and pregnant mice with hyperglycemia, placental FoxO1 expression was significantly increased. Using FoxO1+/- mice, the effects of FoxO1 haploinsufficiency on placental development under normoglycemia and hyperglycemia were investigated. With FoxO1 haploinsufficiency, the term placental weight increased under both normal and hyperglycemic conditions. Under normoglycemia, this weight change was associated with a general enlargement of the labyrinth, along with increased cell proliferation, decreased cell apoptosis, and decreased expression of p21, p27, Casp3, Casp8, and Rip3. However, under hyperglycemia, the placental weight change was associated with increased fetal blood space, VEGFA overexpression, and expression changes of the angiogenic markers, Eng and Tsp1. In conclusion, FoxO1 plays a role in regulating cell proliferation, cell survival, or angiogenesis, depending on blood glucose levels, during placenta development.

UI MeSH Term Description Entries
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000071161 Forkhead Box Protein O1 A forkhead box transcription factor that is a major target of INSULIN signaling and regulator of metabolic homeostasis in response to OXIDATIVE STRESS. It binds to the insulin RESPONSE ELEMENT (IRE) and the related Daf-16 family binding element (DBE). Its activity is suppressed by insulin and it also regulates OSTEOBLAST proliferation, controls bone mass, and skeletal regulation of GLUCOSE metabolism. It promotes GLUCONEOGENESIS in HEPATOCYTES and regulates gene expression in ADIPOSE TISSUE. It is also an important CELL DEATH regulator. Chromosomal aberrations involving the FOXO1 gene occur in RHABDOMYOSARCOMA. FOXO1 Protein,Forkhead in Rhabdomyosarcoma Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016640 Diabetes, Gestational Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA. Diabetes Mellitus, Gestational,Diabetes, Pregnancy-Induced,Gestational Diabetes,Diabetes, Pregnancy Induced,Gestational Diabetes Mellitus,Pregnancy-Induced Diabetes
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
February 2001, Arteriosclerosis, thrombosis, and vascular biology,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
August 2008, Oncogene,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
January 2014, Journal of Cancer,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
January 2019, Frontiers in immunology,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
March 2015, Cardiovascular research,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
July 2018, The Journal of pathology,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
February 2021, Cell proliferation,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
January 2004, Tissue engineering,
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
March 2015, Molecular endocrinology (Baltimore, Md.),
Zehuan Ding, and Naomi McCauley, and Yushu Qin, and Lauren Lawless, and Shaodong Guo, and Lanjing Zhang, and Ke K Zhang, and Linglin Xie
October 2015, Oncogene,
Copied contents to your clipboard!